PTC Therapeutics Aktie
37,60
EUR
-1,40
EUR
-3,59
%
44,69
USD
-1,62
USD
-3,50
%
Werbung
PTC Therapeutics Aktie Analyse
29.01.18 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
29.09.17 | PTC Therapeutics Equal weight | Barclays Capital | |
29.09.17 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
16.03.17 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
03.03.17 | PTC Therapeutics Equal weight | Barclays Capital | |
11.11.16 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
01.03.16 | PTC Therapeutics Neutral | Wedbush Morgan Securities Inc. | |
01.03.16 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
Werbung
|
|||
24.02.16 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
05.05.15 | PTC Therapeutics Neutral | ROTH Capital Partners, LLC |
Werbung
Werbung